| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1012822491 |
| P356 | DOI | 10.1007/S40139-012-0004-5 |
| P932 | PMC publication ID | 3601800 |
| P698 | PubMed publication ID | 23524956 |
| P5875 | ResearchGate publication ID | 236076791 |
| P2093 | author name string | Florin M Selaru | |
| Masaharu Ishida | |||
| P2860 | cites work | Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs | Q24302072 |
| MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion | Q24305799 | ||
| Sequence-specific inhibition of microRNA- and siRNA-induced RNA silencing | Q24537549 | ||
| MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells | Q24596316 | ||
| Efficient inhibition of miR-155 function in vivo by peptide nucleic acids | Q24603017 | ||
| MicroRNAs: target recognition and regulatory functions | Q24609584 | ||
| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 | Q24617130 | ||
| Regression of murine lung tumors by the let-7 microRNA | Q24621218 | ||
| Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes | Q24628676 | ||
| Downregulation of miR-122 in the rodent and human hepatocellular carcinomas | Q24631076 | ||
| Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis | Q24634165 | ||
| MicroRNA biogenesis: there's more than one way to skin a cat | Q24642062 | ||
| MicroRNA let-7: an emerging next-generation cancer therapeutic | Q24644251 | ||
| MicroRNA expression, survival, and response to interferon in liver cancer | Q24647241 | ||
| Suppression of non-small cell lung tumor development by the let-7 microRNA family | Q24651985 | ||
| Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model | Q24655262 | ||
| Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression | Q24681466 | ||
| Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
| The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 | Q27860849 | ||
| Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
| Processing of primary microRNAs by the Microprocessor complex | Q27860986 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| Single-stranded antisense siRNAs guide target RNA cleavage in RNAi | Q28201784 | ||
| MicroRNA-26a promotes cholangiocarcinoma growth by activating β-catenin | Q28263940 | ||
| The let-7 microRNA reduces tumor growth in mouse models of lung cancer | Q28272817 | ||
| Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 | Q28285980 | ||
| The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | Q28297958 | ||
| MicroRNA-192 and -215 are upregulated in human gastric cancer in vivo and suppress ALCAM expression in vitro | Q28299575 | ||
| MicroRNAs as therapeutic targets | Q28302308 | ||
| MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis | Q28509140 | ||
| MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts | Q28511032 | ||
| miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting | Q29547487 | ||
| MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer | Q29547523 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| LNA-mediated microRNA silencing in non-human primates | Q29615962 | ||
| Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways | Q29618467 | ||
| microRNA-34a is tumor suppressive in brain tumors and glioma stem cells | Q30428366 | ||
| A simple Bayesian estimate of direct RNAi gene regulation events from differential gene expression profiles | Q31012608 | ||
| Antagomir-17-5p abolishes the growth of therapy-resistant neuroblastoma through p21 and BIM | Q33336561 | ||
| MicroRNA let-7a inhibits proliferation of human prostate cancer cells in vitro and in vivo by targeting E2F2 and CCND2. | Q33564111 | ||
| MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. | Q33575825 | ||
| Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship | Q33719798 | ||
| RNAi experiments in D. melanogaster: solutions to the overlooked problem of off-targets shared by independent dsRNAs | Q33721873 | ||
| MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors | Q33755320 | ||
| Efficient delivery of small interfering RNA to bone-metastatic tumors by using atelocollagen in vivo. | Q33913718 | ||
| miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis | Q34044475 | ||
| MicroRNA delivery by cationic lipoplexes for lung cancer therapy | Q34060310 | ||
| MicroRNA-211 expression promotes colorectal cancer cell growth in vitro and in vivo by targeting tumor suppressor CHD5 | Q34123881 | ||
| MicroRNA sponges: progress and possibilities | Q34139023 | ||
| Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer | Q34248844 | ||
| Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. | Q34271727 | ||
| Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny | Q34623669 | ||
| Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy | Q34915120 | ||
| Knockdown of miR-21 in human breast cancer cell lines inhibits proliferation, in vitro migration and in vivo tumor growth | Q35029501 | ||
| Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice | Q35086711 | ||
| MiR-100 regulates cell differentiation and survival by targeting RBSP3, a phosphatase-like tumor suppressor in acute myeloid leukemia. | Q35659883 | ||
| MicroRNA let-7c suppresses androgen receptor expression and activity via regulation of Myc expression in prostate cancer cells | Q35668910 | ||
| miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells. | Q35889599 | ||
| Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. | Q35902685 | ||
| MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis | Q36129123 | ||
| Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. | Q36129129 | ||
| Coordinated effects of microRNA-494 induce G₂/M arrest in human cholangiocarcinoma | Q36130078 | ||
| Silencing of microRNA families by seed-targeting tiny LNAs | Q36522844 | ||
| Potent and nontoxic antisense oligonucleotides containing locked nucleic acids | Q36985622 | ||
| Advances in microRNAs: implications for gene therapists | Q37037641 | ||
| Potent inhibition of microRNA in vivo without degradation | Q37041859 | ||
| RNAs as extracellular signaling molecules | Q37121371 | ||
| Cancerous miRNAs and their regulation | Q37158988 | ||
| Knocking down barriers: advances in siRNA delivery | Q37380671 | ||
| Developing therapeutic microRNAs for cancer | Q37543146 | ||
| Self-assembled RNA interference microsponges for efficient siRNA delivery | Q37662457 | ||
| MicroRNAs and the cell cycle | Q37840505 | ||
| Clinical potential of microRNAs in pancreatic ductal adenocarcinoma. | Q37946163 | ||
| Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. | Q37950261 | ||
| Developing microRNA therapeutics | Q37981141 | ||
| MicroRNAs as therapeutic targets and their potential applications in cancer therapy | Q38018097 | ||
| The principles of MiRNA-masking antisense oligonucleotides technology | Q38340276 | ||
| Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosis | Q38342043 | ||
| MicroRNA-21 inhibition enhances in vitro chemosensitivity of temozolomide-resistant glioblastoma cells. | Q39321003 | ||
| MicroRNA-21 inhibits Serpini1, a gene with novel tumour suppressive effects in gastric cancer | Q39371738 | ||
| MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway | Q39406412 | ||
| The proto-oncogene Pim-1 is a target of miR-33a | Q39509450 | ||
| Downregulation of Spry2 by miR-21 triggers malignancy in human gliomas | Q39600647 | ||
| MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab | Q39609757 | ||
| Involvement of let-7/miR-98 microRNAs in the regulation of progesterone receptor membrane component 1 expression in ovarian cancer cells. | Q39627053 | ||
| Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells | Q39758746 | ||
| MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2. | Q39789409 | ||
| MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | Q40073679 | ||
| siRNA function in RNAi: a chemical modification analysis | Q42044356 | ||
| Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs | Q45147309 | ||
| MicroRNA-21 promotes the cell proliferation, invasion and migration abilities in ovarian epithelial carcinomas through inhibiting the expression of PTEN protein | Q82270543 | ||
| Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2 | Q84281961 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 63-70 | |
| P577 | publication date | 2012-12-24 | |
| P1433 | published in | Current anesthesiology reports | Q26842367 |
| P1476 | title | miRNA-Based Therapeutic Strategies | |
| P478 | volume | 1 |
| Q34157812 | Aberrantly up-regulated miR-20a in pre-eclampsic placenta compromised the proliferative and invasive behaviors of trophoblast cells by targeting forkhead box protein A1. |
| Q27001694 | Cholangiocarcinoma |
| Q36190977 | Disruption of microRNA-21 by TALEN leads to diminished cell transformation and increased expression of cell-environment interaction genes |
| Q47361566 | Effects of the antagomiRs 15b and 200b on the altered healing pattern of diabetic mice |
| Q48529755 | Function of miR-146a-5p in Tumor Cells As a Regulatory Switch between Cell Death and Angiogenesis: Macrophage Therapy Revisited |
| Q35653311 | Mechanisms of thrombosis in obesity |
| Q49917036 | MicroRNA Replacement: A New Era of Molecular Therapy for Tendon Disorders? |
| Q64963896 | MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR. |
| Q37029400 | MicroRNA-208b Alleviates Post-Infarction Myocardial Fibrosis in a Rat Model by Inhibiting GATA4. |
| Q91798836 | Post-transcriptional regulation of PIAS3 expression by miR-18a in malignant mesothelioma |
| Q37346014 | RNA viruses and microRNAs: challenging discoveries for the 21st century. |
| Q64859159 | Signature of Aberrantly Expressed microRNAs in the Striatum of Rotenone-Induced Parkinsonian Rats |
| Q48611625 | TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis. |
| Q37691772 | The role of microRNAs in skin fibrosis. |
| Q26774954 | To Know How a Gene Works, We Need to Redefine It First but then, More Importantly, to Let the Cell Itself Decide How to Transcribe and Process Its RNAs |
| Q38138933 | miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma. |
| Q40660140 | miRegulome: a knowledge-base of miRNA regulomics and analysis. |
| Q35193913 | mir-34b/c and mir-449a/b/c are required for spermatogenesis, but not for the first cleavage division in mice |
Search more.